July 09, 2016
The main goal of these studies is to evaluate the tolerability of the test item at sites in the body, which may come into contact with the product during clinical use (ocular, cutaneous, transdermal, parenteral). It can be the site of administration or a result of potential unintended/accidental administration.
The local tolerance is evaluated on the basis of the local signs and the histopathological evaluation.
Phone: +49 (0)89 780 7200 10
E-Mail: info(at)aurigon.de